CytoDyn appointed Carl Dockery to the Board of Directors

– USA, WA – CytoDyn Inc.(OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with human immunodeficiency virus (HIV), today announced the appointment of Carl Dockery to its Board of Directors effective September 26, 2014.…